Liver Imaging and Data System (LI-RADS) Version 2018 and Other Imaging Features in Intrahepatic Cholangiocarcinoma in Chinese Adults with vs. without Chronic Hepatitis B Viral Infection

被引:3
|
作者
Liang, Ying-ying [1 ,2 ]
Shao, Shuo [3 ,4 ]
Kuang, Sichi [1 ]
Chen, Jingbiao [1 ]
Zhou, Jing [1 ]
He, Bingjun [1 ]
Zhang, Linqi [1 ]
Zhang, Yao [1 ]
Fowler, Kathryn J. [5 ]
Wang, Jin [1 ]
机构
[1] Sun Yat Sen Univ, Dept Radiol, Affiliated Hosp 1, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China
[2] South China Univ Technol, Guangzhou First Peoples Hosp, Sch Med, Dept Radiol, Guangzhou, Peoples R China
[3] Shandong Univ, Shandong Med Imaging Res Inst, Jinan, Shandong, Peoples R China
[4] Jining 1 Peoples Hosp, Dept Radiol, Jining, Shandong, Peoples R China
[5] Univ Calif San Diego, Dept Radiol, Liver Imaging Grp, La Jolla, CA 92093 USA
基金
中国国家自然科学基金;
关键词
D O I
10.1155/2021/6639600
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose. To describe liver imaging reporting and data system (LI-RADS) version 2018 and other MRI imaging features in intrahepatic mass-forming cholangiocarcinoma (iCCA) in Chinese adults with vs. without chronic hepatitis B viral (HBV) infection. Methods. We retrospectively enrolled 89 patients with pathologically proven iCCA after multiphase imaging performed between 2004 and 2017 at a tertiary medical center in southern China. Based on whether patients had chronic HBV, iCCA was divided into two subgroups: HBV-positive (n = 50 patients, including 9 with cirrhosis) vs. HBV-negative (n = 39 patients, including 14 with hepatolithiasis and 25 with no identifiable risk factor for iCCA; none had cirrhosis). Two independent abdominal radiologists in consensus reviewed the largest mass in each patient to assign LI-RADS v2018 features; they also scored each observation's shape and location. Imaging features were compared using chi-square or Fisher's exact tests. Results. Most iCCAs in HBV-positive (88% (44/50)) and HBV-negative (97% (38/39)) patients had at least one LR-M feature. Compared to iCCAs in HBV-negative patients, iCCAs in HBV-positive patients were more likely to have at least one major feature of HCC (46% (23/50) vs. 8% (3/39), P < 0.001) and more likely to be smooth (42% (21/50) vs. 10% (4/39), P = 0.001). Six of 50 (12%) iCCAs in HBV-positive patients and 1/39 (3%) iCCAs in HBV-negative patients had at least one major feature of HCC without any LR-M feature. Conclusions. In this retrospective single-center study in Chinese adults, iCCAs in HBV-positive patients were more likely to resemble HCCs than iCCAs in HBV-negative patients.
引用
收藏
页数:10
相关论文
共 39 条
  • [31] Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival? (vol 31, pg 6397, 2021)
    Yang, Jie
    Huang, Jia-Yan
    Chen, Xing
    Ling, Wen-Wu
    Luo, Yan
    Shi, Yu-Jun
    Liu, Ji-Bin
    Lu, Qiang
    Lyshchik, Andrej
    EUROPEAN RADIOLOGY, 2022, 32 (03) : 2131 - 2132
  • [32] Role of Intravoxel Incoherent Motion in Discriminating Hepatitis B Virus-Related Intrahepatic Mass-Forming Cholangiocarcinoma from Hepatocellular Carcinoma Based on Liver Imaging Reporting and Data System v2018
    Shao, Shuo
    Shan, Qungang
    Zheng, Ning
    Wang, Bin
    Wang, Jin
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (08) : 511 - 518
  • [33] Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma
    Cannella, Roberto
    Vernuccio, Federica
    Sagreiya, Hersh
    Choudhury, Kingshuk Roy
    Iranpour, Negaur
    Marin, Daniele
    Furlan, Alessandro
    EUROPEAN RADIOLOGY, 2020, 30 (07) : 3770 - 3781
  • [34] Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma
    Roberto Cannella
    Federica Vernuccio
    Hersh Sagreiya
    Kingshuk Roy Choudhury
    Negaur Iranpour
    Daniele Marin
    Alessandro Furlan
    European Radiology, 2020, 30 : 3770 - 3781
  • [35] Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017
    Fei Li
    Qing Li
    Yubo Liu
    Jing Han
    Wei Zheng
    Yini Huang
    Xueyi Zheng
    Longhui Cao
    Jian-hua Zhou
    European Radiology, 2020, 30 : 461 - 470
  • [36] Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017
    Li, Fei
    Li, Qing
    Liu, Yubo
    Han, Jing
    Zheng, Wei
    Huang, Yini
    Zheng, Xueyi
    Cao, Longhui
    Zhou, Jian-hua
    EUROPEAN RADIOLOGY, 2020, 30 (01) : 461 - 470
  • [37] Diagnostic Accuracy of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for Differentiating Between Hepatocellular Carcinoma and Other Hepatic Malignancies in High-Risk Patients: A Meta-Analysis
    Li, Jiawu
    Yang, Lulu
    Ma, Lin
    Lu, Qiang
    Luo, Yan
    ULTRASCHALL IN DER MEDIZIN, 2021, 42 (02): : 187 - 193
  • [38] Assessment of the follow-up interval changes of the less than 2 cm arterial phase enhancing hepatic nodules in correlation with Liver Imaging Reporting and Data System (LI-RADS) classification version 18 using contrast-enhanced multidetector computed tomography
    Sayed M. Mehana
    Egyptian Journal of Radiology and Nuclear Medicine, 50
  • [39] Assessment of the follow-up interval changes of the less than 2cm arterial phase enhancing hepatic nodules in correlation with Liver Imaging Reporting and Data System (LI-RADS) classification version 18 using contrast-enhanced multidetector computed tomography
    Mehana, Sayed M.
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2019, 50 (01):